Key result
CMR and simultaneous inflammatory and injury biomarkers show promise for diagnosing autoimmune myocarditis.
Why the study?
Autoimmune myocarditis develops due to heterogeneous causes including viral infections, systemic autoimmune diseases, immune checkpoint inhibitors, and virus vaccines, with disease type and severity influenced by host genetic factors.
This review highlights the evolving diagnostic landscape for autoimmune myocarditis, emphasizing the utility of cardiac MRI and novel biomarkers over traditional endomyocardial biopsy.
Answers are grounded in this paper and cite their sources.
May aid noninvasive diagnosis of autoimmune myocarditis; leaves open prospective validation before clinical adoption.
INTRODUCTION: Autoimmune myocarditis may develop due to heterogeneous causes. Myocarditis is often caused by viral infections, but it can also be caused by systemic autoimmune diseases. Immune checkpoint inhibitors and virus vaccines induce immune activation, and they can cause the development of myocarditis, as well as several immune-related adverse events. The development of myocarditis is dependent on the genetic factors of the host, and the major histocompatibility complex (MHC) may be an important determinant of the type and severity of the disease. However, non-MHC immunoregulatory genes may also play a role in determining susceptibility. AREA COVERED: This review summarizes the current knowledge of the etiology, pathogenesis, diagnosis, and treatment of autoimmune myocarditis with a particular focus on viral infection, autoimmunity, and biomarkers of myocarditis. EXPERT OPINION: An endomyocardial biopsy may not be the gold standard for the diagnosis of myocarditis. Cardiac magnetic resonance imaging is useful in diagnosing autoimmune myocarditis. Recently identified biomarkers of inflammation and myocyte injury are promising for the diagnosis of myocarditis when measured simultaneously. Future treatments should focus on the appropriate diagnosis of the etiologic agent, as well as on the specific stage of the evolution of immune and inflammatory processes.
No takes yet. Share an insight, caveat, or question.
Akira Matsumori (2023) conducted a review in Autoimmune myocarditis. Cardiac magnetic resonance imaging and simultaneously measured biomarkers of inflammation and myocyte injury are promising tools for the diagnosis of autoimmune myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: